Mesoporous silica- and silicon-based materials ... - Helda - Helsinki.fi
Mesoporous silica- and silicon-based materials ... - Helda - Helsinki.fi
Mesoporous silica- and silicon-based materials ... - Helda - Helsinki.fi
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
4.1.3 Cell culture (IV)<br />
Human colon adenocarcinoma Caco-2 cells were obtained from American Type Culture<br />
Collection. The cells were grown in a medium consisting of Dulbecco’s Modi<strong>fi</strong>ed Eagle<br />
Medium (4.5 g/l glucose) supplemented with 10% Fetal Bovine Serum (heat inactivated at<br />
56 °C for 30 min), 1% Non Essential Amino Acids, 1% L-glutamine (200 mM), penicillin<br />
(100 IU/ml), <strong>and</strong> streptomycin (100 µg/ml). The cultures were maintained at 37 °C in an<br />
incubator at an atmosphere of 5% CO2 <strong>and</strong> 95% relative humidity. The growth medium<br />
was changed three times a week during cell growth <strong>and</strong> differentiation. The cells were<br />
seeded at 6.8 × 10 4 cells/cm 2 onto polycarbonate <strong>fi</strong>lter membranes (pore size 0.4 µm,<br />
growth area 1.1 cm 2 ) in 12-Transwell inserts. Cells from passage numbers 31–42 were<br />
used in the experiments at ages ranging from 21 to 28 days.<br />
4.1.4 Dissolution media <strong>and</strong> other chemicals (I-IV)<br />
Buffered Hank’s balanced salt solution (HBSS) was used as a medium in drug release<br />
studies (I, IV). Biological buffers HEPES (4-(2-Hydroxyethyl)piperazine-1ethanesulfonic<br />
acid) or MES [2-(N-Morpholino)ethanesulfonic acid] at 10 mM<br />
concentration were used to buffer the HBSS. 0.2M HCl / 0.2 M KCl was the buffer used at<br />
pH 1.2 (II). In the experiments including a pH change from 1.2 to 6.8, 0.1 M HCl solution<br />
was used as the initial medium at pH 1.2, which was further raised to pH 6.8 by adding 0.2<br />
M Na3PO4 solution (II). At pH 5.5, 0.1 M phosphate buffer was used (III).<br />
Solvents used in the sample manufacture <strong>and</strong> analysis were EtOH (I-IV), phosphoric<br />
acid (I-IV), acetonitrile (I, IV), dichloromethane (III), methanol (IV), dimethylsulfoxide<br />
(DMSO) (IV) <strong>and</strong> octanol (IV). D-[ 14 C]mannitol solution was used to assess the Caco-2<br />
monolayer integrity after the permeation studies. Excipients in tablet formulations (III)<br />
were Avicel PH 102 (microcrystalline cellulose), Ac–Di–Sol (croscarmellose sodium),<br />
Aerosil 200 (colloidal <strong>silica</strong>), Kollidon 30 (polyvinylpyrrolidone), Pharmatose 200 M<br />
(lactose monohydrate) <strong>and</strong> magnesium stearate.<br />
4.2 Loading of mesoporous microparticles (I-IV)<br />
Immersion loading method (I-IV)<br />
In the immersion loading method the drug was <strong>fi</strong>rst dissolved in an appropriate solvent at<br />
the following concentrations: ibuprofen (I) 800 mg/ml in EtOH, IMC 180 mg/ml <strong>and</strong> 250<br />
mg/ml (II) or 17 mg/ml (III) in EtOH, <strong>and</strong> furosemide (IV) 600 mg/ml in DMSO. The<br />
loading was performed at room temperature, except for IMC loading in publication II,<br />
where heated EtOH at 68±2 °C was used as a solvent. The mesoporous particles were<br />
added <strong>and</strong> the suspension stirred for at least 1 h. After the loading, the suspension was<br />
<strong>fi</strong>ltered <strong>and</strong> the loaded particles were dried in an oven. The drying temperature varied<br />
between 60 <strong>and</strong> 120 °C depending on the solvent.<br />
30